Mutations in the KDM5C gene (Xp11.22-p11.21) have beenshown to cause an X-linked recessive syndromic mental retardation.Phenotypic features that have been reported include facial hypotonia, maxillaryhypoplasia, strabismus, large ears with raised lobes, big hands with largefingers and proximal thumbs, prominent and separated superior incisors, scrotaltongue, and pectus excavatum. Other features of this syndrome can include slowlyprogressive spastic paraplegia, epileptic seizures, short stature,microcephaly, hypermetropia, and small feet, testes, and penis. Aggressivebehavior and an overfriendly and anxious character have also been reported.
The phenotype associatedwith mutations in the KDM5C gene isvariable with regard to dysmorphism and cognitive impairment. In some families,the X-linked mental retardation seems to be nonsyndromic, with no dysmorphicfeatures. It has been estimated that the frequency of mutations in the KDM5C gene may account for 2.8% to3.3% of families with XLMR.
For patients with suspected KDM5C-related syndromic XLMR, sequence analysis is recommended as the first step in mutation identification. For patients in whom mutations are not identified by full gene sequencing, deletion/duplication analysis is appropriate.
Click here for the OMIM summary on this condition.
This test is indicated for:
- Confirmation of a clinical diagnosis of JARID1C-related syndromic XLMR
- Carrier testing in adult females with a family history of JARID1C-related syndromic XLMR
Clinical Sensitivity: Unknown. It has been estimated that the frequency of mutations in the JARID1C gene may account for 2.8% to 3.3% of families with XLMR. Mutations in the promoter region, some mutations in the introns and other regulatory element mutations cannot be detected by this analysis. Large deletions will not be detected by this analysis. Results of molecular analysis should be interpreted in the context of the patient's biochemical phenotype.
Analytical Sensitivity: ~99%
Isolation using the Perkin Elmer™Chemagen™ Chemagen™ Automated Extraction method or Qiagen™ Puregene kit for DNA extraction is recommended.
Orangene™ Saliva Collection Kit used according to manufacturer instructions. Please contact EGL for a Saliva Collection Kit for patients that cannot provide a blood sample.
Infants and Young Children (<2 years of age): 2-3 ml
Children > 2 years of age to 10 years old: 3-5 ml
Older Children & Adults: 5-10 ml
Autopsy: 2-3 ml unclotted cord or cardiac blood
Submit copies of diagnostic biochemical test results with the sample, if appropriate. Contact the laboratory if further information is needed.
Sequence analysis is required before deletion/duplication analysis by targeted CGH array. If sequencing is performed outside of EGL Genetics, please submit a copy of the sequencing report with the test requisition.
- Deletion/duplication analysis of the KDM5C gene by CGH array is available for those individuals in whom sequence analysis is negative (YK).
- A CGH array-based test for deletion/duplication analysis of 109 different X-linked intellectual disability genes is available (OL).
- Custom diagnostic mutation analysis (KM) is available to family members if mutations are identified by targeted mutation testing or sequencing analysis.
- Prenatal testing is available to adult females who are confirmed carriers of mutations. Please contact the laboratory genetic counselor to discuss appropriate testing prior to collecting a prenatal specimen.